Aridis Pharmaceuticals, Inc. (ARDS:OTC) closed at $0.000 on October 22, 2026, unchanged on the day. It is trading at its 52-week low of $0.000. Aridis Pharmaceuticals, Inc. is part of the Health Care sector (Major Pharmaceuticals).
Aridis Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is engaged in the discovery and development of targeted immunotherapy using fully human monoclonal antibodies, or mAbs, to treat life-threatening infections.
Find more stocks like ARDS with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.